Since 2008, MS Research Australia has coordinated a national collaborative genetics platform known as ANZgene to facilitate DNA

The results of a Phase II clinical trial looking at the effects of a new therapy, ozanimod,for relapsing

There is a great deal of interest within the MS community, as with many other chronic health conditions,

Although many risk factors for MS have been identified, the exact causes and triggers for the disease are

This year, the Ian Ballard Travel Awards were awarded to two promising researchers in Queensland and Western Australia.

In keeping with the MS Research Australia three year Strategic Plan, an independent Leadership Council has been established.

Kiss Goodbye to MS is MS Research Australia’s national fundraising initiative, raising money for research into MS. In

Following an earlier report in 2014 of disappointing preliminary results from a phase III clinical trial of Gilenya (fingolimod)

MS Research Australia is delighted to announce that $1.834 in funding has been awarded to new research projects